Controlled release approach to novel multiparticulate drug delivery system

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL.3, 2012, Pages 757-763

  Patwekar, Shailesh L ^a   Baramade, Mahesh K ^a  

^a SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

Chronotherapeutics; CODAS; DIFFUCAPS; OROS; PRODAS

Indexed keywords

ARTICLE; CIRCADIAN RHYTHM; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; OSMOSIS; PARTICLE SIZE; PULSATILE DRUG RELEASE;

EID: 84870737867     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gurvinder Singh Rekhi. advances in solid dose oral drug delivery. Frederick Furness Publishing 2010.
2. Parul B. Patel, Avinash S. Dhake. Multiparticulate approach: an emerging trend in colon specific drug delivery for Chronotherapy. Journal of Applied Pharmaceutical Science 01 (05); 2011: 59-63.
3. Laila F. A. A., Chandran S. Multiparticulate Formulation approach to colon specific drug delivery current perspectives. J. Pharm Pharm Sci, 2006, 9(3): 327-338.
4. Pallab Roy, Aliasgar Shahiwala. Multiparticulate formulation approach to pulsatile drug delivery: Current perspectives. Journal of Controlled Release 134 (2009) 74-80.
5. NS Dey, S Majumdar, MEB Rao. Multiparticulate Drug Delivery Systems for Controlled Release. Trop J Pharm Res, September 2008.
6. Shaji J., Chadawar V., Talwalkar P. Multiparticulate Drug Delivery System. The Indian Pharmacist, June 2007, 6(60): 21-28.
7. Dvane, John G, Stark, Paul, Fanning, Niall MM. Multiparticulate modified release composition. US Patent No. 4863742 2009.
8. Ueda Y, Hata T, Yamaguchi H, Kotani M, Ueda S. Development of a novel drug release system, time-controlled explosion system (TES). Part 1: concept and design. J Drug Targeting 1994; 2: 35-44.
9. Devane, john G. Sark, Paul, fanning, Niall M. M. Multiparticulate modified release composition. US Patent 6228398.
10. Programmable oral drug absorption system, Elan Corporation, U. S. Patent 75283262, Jun27, 2000.
11. Multiparticulate crystalline drug compositions having controlled release profiles. United States Patent 20050181062, www. freepatentsonline. com.
12. US Patent 6, 110, 494, Article Butler. Pharm. Tech. 1998, 22(3), 122-138.
13. White WB, Mehrotra DV, Black HR, Fakouhi TD. Effects of controlled onset extended release Verapamil on nocturnal blood pressure (dippers versus nondipprs)-verapamil study group. Am J Cardiol 1997; 80: 469-474.
14. Murugesh Shivashankar, Dhandayuthapani Mani. A Brief Overview of Diabetes. Int J Pharm Pharm Sci, Vol 3, Suppl 4, 22-27
15. G. Venkatesh, "Diffucaps® technology for controlled release drug delivery", In. Chronotherapeutics". B.-B. C. Youan (Ed.), John Wiley & Sons, New York (2009) 121-144.
16. Theeuwes F. Push pull OROS system technology. Pharma Tech. 1984; 259.
17. Elan drug technology-CODAS® Technology: http://www. elandrugtechnologies. com/oral_controlled release/codas
18. Shidhaye S. S., Lotlikar V. M., Ghule A. M., Phutane P. K., Kadam V. J. Pulsatile delivery system: An approach for Chronotherapeutic diseases. Sys Rev Pharm. 2010; 1(1): 55-61.
19. Lida E. Kalantzi. Recent Advances in Oral Pulsatile Drug Delivery, Bentham Science Publishers Ltd 2009.
20. Divya. A, K. Kavitha, M. Rupesh Kumar, Dakshayani S, Jagadeesh Singh SD. Bilayer tablet technology: An overview. Journal of Applied Pharmaceutical Science 01 (08); 2011: 43-47
21. Sadhna Khatry, Sirish, Nalini Shastri, Sadanandam. M. Novel drug delivery systems for antifungal therapy. Int j pharm pharm sci, vol 2, issue 4, 6-9.
22. Diffucaps in multiparticulate drug delivery, Eurand S. P. A. Corporation, U. S. Patent 72329344, Feb29, 1972.